Comparative Pharmacology
Head-to-head clinical analysis: NULYTELY FLAVORED versus PLEGISOL IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NULYTELY FLAVORED versus PLEGISOL IN PLASTIC CONTAINER.
NULYTELY-FLAVORED vs PLEGISOL IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
NULYTELY-FLAVORED is an osmotic laxative containing polyethylene glycol (PEG) 3350 and electrolytes. It induces diarrhea by retaining water in the colon through osmotic action, thereby cleansing the bowel.
PLEGISOL is an extracellular-type crystalloid cardioplegic solution used for myocardial protection during cardiac surgery. Its mechanism involves inducing rapid cardiac arrest by high potassium concentration (depolarizing arrest), reducing myocardial oxygen demand, and providing buffering capacity via tromethamine to maintain pH. The solution also contains magnesium to stabilize membranes and mannitol as an osmotic agent to reduce edema.
Adult dose: 4 liters of reconstituted solution orally as a single dose, or 240 mL (8 oz) every 10 minutes until 4 liters are consumed, approximately 1-1.5 hours before colonoscopy.
Administered as an intraperitoneal infusion for organ preservation. Typical adult dose: 2.5-3.0 liters for kidney, 2.5-3.0 liters for liver, 3.0-4.0 liters for pancreas, single dose prior to procurement.
None Documented
None Documented
Not applicable; PEG 3350 is not significantly absorbed and does not exhibit a terminal elimination half-life in the systemic circulation. Clinical effect is due to local osmotic action in the gut.
Not applicable; Plegisol is not a systemically active drug. Its cardioplegic effect is immediate upon perfusion into coronary arteries and dissipates upon reperfusion. The solution's components have endogenous half-lives (e.g., potassium: 1-1.5 h in plasma), but this is not clinically relevant for the product.
Primarily fecal elimination as unabsorbed PEG 3350; minimal systemic absorption (<0.06%). Renal excretion of absorbed fraction is negligible.
Plegisol is an extracellular cardioplegic solution; its components (electrolytes and calcium) are not metabolized. Elimination of infused volume occurs primarily via renal excretion (approx. 95%) as unchanged water and electrolytes; minor biliary/fecal elimination (<5%) accounts for negligible electrolyte loss.
Category C
Category C
Osmotic Laxative
Osmotic Laxative